Skip to main content
ABCL logo

ABCL · AbCellera Biologics Inc.

$5.97 +0.17 (+2.93%) At close · Jul 21
Market Cap
$1.82B
Shares
305.38M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-06-30 340,401 $8.12 $2,764,056
2026-06-29 347,508 $7.38 $2,564,609
2026-06-26 26,684 $6.66 $177,715
2026-06-25 357,537 $6.03 $2,155,948
2026-06-24 40,305 $5.63 $226,917
2026-06-23 159,389 $5.74 $914,893
2026-06-22 248,120 $5.53 $1,372,104
2026-06-18 25,813 $5.44 $140,423
2026-06-17 98,907 $5.09 $503,437
2026-06-16 57,554 $5.26 $302,734
2026-06-15 17,505 $5.24 $91,726
2026-06-12 1,195 $5.27 $6,298
2026-06-11 374,142 $5.09 $1,904,383
2026-06-10 151,102 $5.30 $800,841
2026-06-09 3,865 $5.42 $20,948
2026-06-08 47,789 $5.62 $268,574
2026-06-05 57,266 $6.37 $364,784
2026-06-04 171,134 $5.72 $978,886
2026-06-03 242,149 $6.13 $1,484,373
2026-06-02 93,555 $6.46 $604,365
2026-06-01 95,529 $6.17 $589,414
2026-05-29 55,250 $5.73 $316,583
2026-05-28 156,170 $5.44 $849,565
2026-05-27 143,686 $5.29 $760,099
2026-05-26 206,354 $5.20 $1,073,041
2026-05-22 249,478 $5.14 $1,282,317
2026-05-21 314,937 $4.57 $1,439,262
2026-05-20 454,804 $4.05 $1,841,956
2026-05-19 828,334 $4.16 $3,445,869
2026-05-18 328,076 $4.09 $1,341,831
2026-05-15 123,972 $4.40 $545,477
2026-05-14 84,559 $4.77 $403,346
2026-05-13 50,335 $4.95 $249,158
2026-05-12 108,660 $5.25 $570,465
2026-05-11 55,208 $5.24 $289,290
2026-05-08 17,974 $4.82 $86,635
2026-05-07 80,098 $5.04 $403,694
2026-05-06 376,377 $4.66 $1,753,917
2026-05-05 73,828 $4.59 $338,871
2026-05-04 25,166 $4.43 $111,485
2026-05-01 99,534 $4.15 $413,066
2026-04-30 286,808 $3.82 $1,095,607
2026-04-29 1,786,958 $4.16 $7,433,745
2026-04-28 619,362 $4.16 $2,576,546
2026-04-27 1,340 $4.15 $5,561
2026-04-24 889 $4.05 $3,600
2026-04-23 1,389 $4.08 $5,667
2026-04-22 2,606 $3.99 $10,398
Showing 1–48 of 48 settlements
Key facts CIK 1703057 CUSIP 00288U106 13F (30d) 10 filings 10 filers Visit website Investor relations